» Authors » P N A Harris

P N A Harris

Explore the profile of P N A Harris including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 173
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stewart A, Price E, Schabacker K, Birikmen M, Harris P, Choong K, et al.
Antimicrob Agents Chemother . 2021 Mar; 65(6). PMID: 33781999
Third-generation cephalosporin-resistant (3GC-R) represent a major threat to human health. Here, we captured 288 3GC-R clinical isolates from 264 patients presenting at a regional Australian hospital over a 14-month period....
2.
Henderson A, Paterson D, Chatfield M, Tambyah P, Lye D, De P, et al.
Clin Infect Dis . 2020 Oct; 73(11):e3842-e3850. PMID: 33106863
Introduction: This study aims to assess the association of piperacillin/tazobactam and meropenem minimum inhibitory concentration (MIC) and beta-lactam resistance genes with mortality in the MERINO trial. Methods: Blood culture isolates...
3.
Denny K, De Waele J, Laupland K, Harris P, Lipman J
Clin Microbiol Infect . 2020 Jan; 26(6):801. PMID: 31968270
No abstract available.
4.
McNamara J, Harris P, Chatfield M, Lorenc P, Paterson D
Clin Microbiol Infect . 2019 Oct; 26(2):257.e1-257.e4. PMID: 31654791
Objectives: To evaluate the sequential organ failure assessment (SOFA) and modified SOFA (mSOFA) scoring and a novel performance score based on the Karnofsky score for measuring outcome following a bloodstream...
5.
Denny K, De Waele J, Laupland K, Harris P, Lipman J
Clin Microbiol Infect . 2019 Jul; 26(1):35-40. PMID: 31306790
Background: Most intensive care unit (ICU) patients receive broad-spectrum antibiotics. While lifesaving in some, in others these treatments may be unnecessary and place patients at risk of antibiotic-associated harms. Objectives:...
6.
Harris P, McNamara J, Lye D, Davis J, Bernard L, Cheng A, et al.
Clin Microbiol Infect . 2016 Nov; 23(8):533-541. PMID: 27810466
Objectives: To define standardized endpoints to aid the design of trials that compare antibiotic therapies for bloodstream infections (BSI). Methods: Prospective studies, randomized trials or registered protocols comparing antibiotic therapies...
7.
8.
Harris P, Ferguson J
Int J Antimicrob Agents . 2012 Jul; 40(4):297-305. PMID: 22824371
Some bacteria that possess chromosomally determined AmpC β-lactamases may express these enzymes at a high level following exposure to β-lactams, either by induction or selection for derepressed mutants. This may...